GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
I

Immunotech Laboratories IMMB · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Immunotech Laboratories — daily IMMB Delayed
Market value
$8
Last close × shares
Volume
244.2k
Shares, 30 Oct 2026

About Immunotech Laboratories

Its shares trade under the ticker IMMB. It has been listed since 7 January 2002.

Immunotech Laboratories, Inc. is a drug development company. The company is headquartered in Monrovia California, California. The company went IPO on 2002-01-07. The firm offers a drug platform, Irreversible Pepsin Fraction (IPF), which is a technology that can be used to facilitate a range of applications. Its flagship compound Immune Therapeutic Vaccine-1 (ITV-1) is a suspension of IPF, which is used in the treatment of human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS) and Hepatitis C viruses and to modulate the immune system. IPF is the active drug substance of ITV-1 and is a purified extract of porcine pepsin. The IPF modulates helper T1 cells expression of elaborate cytokines interferon (INF)-gamma, interleukin-2 (IL-2), which selectively promotes cell-mediated immune response and subsequently stimulates cytotoxic lymphocytes. The firm's other compounds in its pipeline include ITV-2 prenatal, ITV-3 Pediatric and ITV-4 HIV Vaccine.

Figures and description from our data supplier, not checked against the company's own report.

More about Immunotech Laboratories →

Latest on Immunotech Laboratories

Our reporting

We have not reported on Immunotech Laboratories yet.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Immunotech Laboratories's ticker?

Immunotech Laboratories trades as IMMB on its US listing, under ISIN US45254F2039.

What was Immunotech Laboratories's last closing price?

0.00 on 30 Oct 2026. The figure is in USD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.